IV 
118TH CONGRESS 
2D SESSION 
H. RES. 1613 
Recognizing the importance of a continued commitment to ending pediatric 
HIV/AIDS worldwide. 
IN THE HOUSE OF REPRESENTATIVES 
DECEMBER 10, 2024 
Ms. MCCLELLAN (for herself, Mr. SWALWELL, Ms. GARCIA of Texas, Mr. 
JOHNSON of Georgia, Mr. QUIGLEY, Mr. GRIJALVA, Ms. ROSS, Mrs. 
CHERFILUS-MCCORMICK, Mrs. WATSON COLEMAN, Ms. WILSON of Flor-
ida, Mr. JACKSON of Illinois, Ms. VELA´ZQUEZ, Ms. SEWELL, Ms. WIL-
LIAMS of Georgia, Mr. GARAMENDI, Ms. NORTON, Mrs. MCIVER, Mr. 
VEASEY, Ms. KELLY of Illinois, Ms. CLARKE of New York, Mr. MCGOV-
ERN, Mr. POCAN, Mr. DAVIS of Illinois, Mr. KRISHNAMOORTHI, Mr. CAR-
TER of Louisiana, and Mr. THOMPSON of Mississippi) submitted the fol-
lowing resolution; which was referred to the Committee on Foreign Af-
fairs, and in addition to the Committee on Energy and Commerce, for 
a period to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the com-
mittee concerned 
RESOLUTION 
Recognizing the importance of a continued commitment to 
ending pediatric HIV/AIDS worldwide. 
Whereas approximately half of the 39,000,000 people living 
with the human immunodeficiency virus (HIV), the 
pathogen that causes the acquired immune deficiency 
syndrome (AIDS), worldwide are women and girls, and 
1,400,000 are children in 2023; 
VerDate Sep 11 2014 
02:26 Dec 11, 2024
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR1613.IH
HR1613
kjohnson on DSK7ZCZBW3PROD with $$_JOB
•HRES 1613 IH 
Whereas HIV is a leading cause of death among women of 
childbearing age worldwide; 
Whereas AIDS is a leading cause of death among adolescent 
girls globally; 
Whereas women around the world rely on essential pre- and 
post-natal care to provide screening for diseases such as 
HIV and care for their health and the health of their in-
fants; 
Whereas, when antiretroviral drugs are used as prophylaxis, 
mother-to-child transmission of HIV can be reduced to 
less than 5 percent; 
Whereas, in 2005, only 17 percent of pregnant and 
breastfeeding women living with HIV were receiving 
treatment and services for prevention of mother-to-child 
transmission and that number in 2023 was 84 percent; 
Whereas 44 percent of new HIV infections globally are 
among women and girls in 2023; 
Whereas, globally, 67 percent of infants born to pregnant 
women living with HIV receive a virologic test within the 
first two months of birth; 
Whereas, without treatment half of all children with HIV will 
die by their second birthday, and 80 percent by their 
fifth birthday; 
Whereas, in 2018, nearly 90 percent of pregnant women liv-
ing with HIV in need of HIV services worldwide live in 
sub-Saharan Africa; 
Whereas 86 percent of children living with HIV are in sub- 
Saharan Africa; 
VerDate Sep 11 2014 
02:26 Dec 11, 2024
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HR1613.IH
HR1613
kjohnson on DSK7ZCZBW3PROD with $$_JOB
•HRES 1613 IH 
Whereas, despite increased global and United States efforts, 
over 110,000 children in Sub-Saharan Africa became in-
fected with HIV in 2022; 
Whereas progress in meeting the global 95-95-95 treatment 
targets by 2030, which calls for 95 percent of those living 
with HIV to know their status; 95 percent of those who 
know their status to be on treatment; and 95 percent of 
those on treatment to be virally suppressed and sus-
tained, is slower among children than adults; 
Whereas 57 percent of children living with HIV were on life- 
saving antiretroviral therapy in 2023 compared to 77 
percent of adults globally; 
Whereas 76,000 children died of AIDS-related causes in 
2023; 
Whereas, every week, approximately 4,000 adolescent girls 
and young women aged 15 to 24 years became infected 
with HIV globally in 2023, and 3,100 of these infections 
occurred in Sub-Saharan Africa. 
Whereas research efforts at the National Institutes of Health 
have led to extraordinary breakthroughs for children in-
fected with and at risk for contracting HIV; 
Whereas the United States began investing in prevention of 
mother-to-child transmission services in 2002 with the 
announcement of the United States International Mother 
and Child HIV Prevention Initiative; 
Whereas, in January 2024, the United States celebrated the 
21st anniversary of the establishment of PEPFAR; 
Whereas, in fiscal year 2023, PEPFAR supported HIV test-
ing and counseling for more than 71,100,000 people and 
since 
the 
program’s 
inception 
the 
provision 
of 
antiretroviral drug prophylaxis to prevent mother-to-child 
VerDate Sep 11 2014 
02:26 Dec 11, 2024
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6300
E:\BILLS\HR1613.IH
HR1613
kjohnson on DSK7ZCZBW3PROD with $$_JOB
•HRES 1613 IH 
transmission has allowed nearly 5,500,000 babies to be 
born HIV free; 
Whereas the PEPFAR DREAMS initiative is working to re-
duce new HIV infections in adolescent and young women 
in 15 sub-Saharan countries; 
Whereas every mother should have the opportunity to fight 
for the life of her child; and 
Whereas every child and adolescent should have access to 
medicines to lead a long and healthy life: Now, therefore, 
be it 
Resolved, That the House of Representatives— 
(1) recognizes that the prevention of mother-to- 
child transmission of HIV is critical to stopping the 
spread of HIV worldwide; 
(2) recognizes that the fight to eliminate pedi-
atric HIV worldwide has been a priority area for the 
United States in its global AIDS response for more 
than 21 years and calls on this leadership to con-
tinue; 
(3) supports providing adolescents and young 
women with the evidence-based approaches necessary 
to prevent new HIV infections; 
(4) supports providing women and children with 
HIV counseling and testing services where possible, 
and scaling up access to services and medicines that 
prevent mother-to-child transmission of HIV and en-
sure HIV positive mothers survive and thrive; 
VerDate Sep 11 2014 
02:26 Dec 11, 2024
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\HR1613.IH
HR1613
kjohnson on DSK7ZCZBW3PROD with $$_JOB
•HRES 1613 IH 
(5) supports scaling up of treatment for HIV 
for children and adolescents including greater access 
to more efficacious antiretroviral drug regimens, age 
appropriate services, and support for their care-
givers; 
(6) applauds the United States leadership on 
efforts to eliminate new pediatric HIV infections and 
to scale-up pediatric treatment through programs 
and research; 
(7) encourages the United States President’s 
Emergency Plan for AIDS Relief to continue its 
leadership through the creation of a standalone pedi-
atric HIV strategy that is in alignment with the pri-
ority actions for children as defined in the ‘‘Global 
AIDS Strategy 2021–2026’’; and 
(8) reaffirms the United States commitment to 
lead the world to the end of AIDS, to eliminate new 
pediatric HIV infections worldwide, and support 
women, children, adolescents, and families infected 
and affected by HIV. 
Æ 
VerDate Sep 11 2014 
02:26 Dec 11, 2024
Jkt 059200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6301
E:\BILLS\HR1613.IH
HR1613
kjohnson on DSK7ZCZBW3PROD with $$_JOB